A Prospective Observational Study of TPIAT

Active, not recruitingOBSERVATIONAL
Enrollment

433

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

April 1, 2024

Study Completion Date

May 1, 2026

Conditions
Pancreatitis, ChronicPancreatectomy; HyperglycemiaPancreatitis
Interventions
PROCEDURE

TPIAT

The entire pancreas is removed to treat the pain of chronic pancreatitis, and the islets are infused back into the patient to reduce diabetes risk after surgery.

Trial Locations (12)

15213

University of Pittsburgh Medical Center, Thomas E. Starzl Transplantation Institute, Pittsburgh

21287

Johns Hopkins Hospital, Baltimore

29425

Medical University of South Carolina, Charleston

40292

University of Louisville, Louisville

43210

The Ohio State University Wexner Medical Center, Columbus

44195

Cleveland Clinic, Cleveland

45229

Cincinnati Children's Hospital Medical Center, Cincinnati

55455

University of Minnesota, Minneapolis

60637

The University of Chicago Medical Center, Chicago

75246

Baylor University Medical Center, Dallas

94143

University of California, San Francisco, San Francisco

03756

Dartmouth-Hitchcock Medical Center, Lebanon

All Listed Sponsors
collaborator

Baylor Health Care System

OTHER

collaborator

Medical University of South Carolina

OTHER

collaborator

University of Chicago

OTHER

collaborator

University of Pittsburgh Medical Center

OTHER

collaborator

Dartmouth-Hitchcock Medical Center

OTHER

collaborator

Johns Hopkins University

OTHER

collaborator

Children's Hospital Medical Center, Cincinnati

OTHER

collaborator

Ohio State University

OTHER

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

University of Minnesota

OTHER

NCT03260387 - A Prospective Observational Study of TPIAT | Biotech Hunter | Biotech Hunter